Wings Magazine

News
Dr. Gallman directs Mid-Continent Instruments

July 26, 2011, Wichita, Kan. - Mid-Continent Instruments announced the appointment of Dr. John W. Gallman to the position of Division Director for the company’s True Blue Power division.


July 26, 2011  By Carey Fredericks

A veteran of more than 20 ­years in business aviation, Gallman began his career at the NASA Ames Research Center after earning his undergraduate and masters degrees in Aeronautics and Astronautics from Purdue University, adding a Ph.D. in Aeronautics and Astronautics from Stanford University in 1992.

Prior to joining Mid-Continent Instruments, Gallman spent eight years at Cessna Aircraft Company. During his tenure at Cessna, Gallman served as the Principal Engineer for Technology Development, managing the company’s technology scouting, assessing business and technical risks, reviewing intellectual property and leading prototype demonstrations.

At NASA Ames, Gallman worked with Learjet and Raytheon Aircraft, gaining valuable experience as the leader of collaborative programs on aircraft conceptual design, aerodynamic shape optimization and high speed wind tunnel testing. He later joined Raytheon Aircraft Corporation in 1996 as Manager of Preliminary Design, progressing to Program Manager and Chief Engineer on the Hawker 450 program. Gallman transitioned the Beechcraft Premier I from FAA type certification to production delivery as Chief Engineer of the program in 2001 and 2002.

“I’m pleased to be a part of the growth of the True Blue Power division at Mid-Continent Instruments,” Gallman said. “Many of the True Blue Power products have a unique focus on state-of-the-art lithium-ion batteries. Leveraging Mid-Continent’s experience in aircraft instruments enables easy integration of innovative power solutions into the cockpit to manage and monitor aircraft power. That foundation also provides us with an obvious platform from which to work with customers to identify their specific needs and design custom solutions.”

Advertisement

Advertisement

Stories continue below